Nektar Therapeutics (NKTR) Insider Trading
- $1,135,850.00
- $232,543,735.70
- Nov. 19, 2024
- Howard W Robin
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
July 21, 2021 | Director | 3,524 | $16.81 | Sell | $59,238.44 | |
May 17, 2021 | SVP | 1,917 | $18.30 | Sell | $35,081.10 | |
May 17, 2021 | Insider | 31,111 | $18.30 | Sell | $569,331.30 | |
May 17, 2021 | CFO | 7,898 | $18.30 | Sell | $144,533.40 | |
May 17, 2021 | CAO | 13,391 | $18.30 | Sell | $245,055.30 | |
May 17, 2021 | CEO | 11,560 | $18.30 | Sell | $211,548.00 | |
May 12, 2021 | Director | 8,000 | $19.34 | Sell | $154,720.00 | |
April 14, 2021 | Director | 8,000 | $18.98 | Sell | $151,840.00 | |
Feb. 4, 2021 | CFO | 50,000 | $19.81 | Sell | $990,500.00 | |
Feb. 3, 2021 | SVP | 5,344 | $19.45 | Sell | $103,940.80 | |
Feb. 3, 2021 | CEO | 150,000 | $19.72 | Sell | $2,958,000.00 | |
Feb. 2, 2021 | CFO | 50,000 | $20.17 | Sell | $1,008,500.00 | |
Jan. 28, 2021 | CAO | 75,000 | $18.62 | Sell | $1,396,500.00 | |
Dec. 15, 2020 | Director | 1,560 | $17.82 | Sell | $27,799.20 | |
Nov. 23, 2020 | Insider | 16,380 | $16.40 | Sell | $268,632.00 | |
Sept. 28, 2020 | Director | 3,250 | $17.25 | Sell | $56,062.50 | |
Sept. 25, 2020 | Director | 5,500 | $17.75 | Sell | $97,625.00 | |
Sept. 21, 2020 | Director | 2,250 | $19.74 | Sell | $44,415.00 | |
Sept. 17, 2020 | CFO | 2,000 | $19.96 | Sell | $39,920.00 | |
Sept. 8, 2020 | Director | 8,000 | $18.53 | Sell | $148,240.00 | |
Aug. 17, 2020 | CAO | 1,367 | $19.67 | Sell | $26,888.89 | |
Aug. 17, 2020 | CEO | 11,885 | $19.67 | Sell | $233,777.95 | |
Aug. 17, 2020 | SVP | 1,529 | $19.67 | Sell | $30,075.43 | |
Aug. 17, 2020 | CFO | 6,245 | $19.67 | Sell | $122,839.15 | |
Aug. 17, 2020 | Insider | 26,200 | $19.67 | Sell | $515,354.00 | |
July 9, 2020 | Director | 15,009 | $25.00 | Sell | $375,225.00 | |
April 15, 2020 | Director | 8,000 | $18.38 | Sell | $147,040.00 | |
March 11, 2020 | Director | 8,000 | $16.79 | Sell | $134,320.00 | |
Feb. 18, 2020 | CEO | 8,448 | $22.35 | Sell | $188,812.80 | |
Feb. 18, 2020 | CFO | 5,938 | $22.35 | Sell | $132,714.30 | |
Feb. 18, 2020 | CAO | 1,394 | $22.35 | Sell | $31,155.90 | |
Feb. 18, 2020 | Insider | 4,774 | $22.35 | Sell | $106,698.90 | |
Feb. 12, 2020 | Director | 8,000 | $23.50 | Sell | $188,000.00 | |
Feb. 6, 2020 | CAO | 37,500 | $22.78 | Sell | $854,250.00 | |
Nov. 18, 2019 | CFO | 8,863 | $17.97 | Sell | $159,268.11 | |
Nov. 18, 2019 | Insider | 3,960 | $17.97 | Sell | $71,161.20 | |
Nov. 18, 2019 | CAO | 2,713 | $17.97 | Sell | $48,752.61 | |
Nov. 18, 2019 | CEO | 13,556 | $17.97 | Sell | $243,601.32 | |
Nov. 13, 2019 | CFO | 25,000 | $19.79 | Sell | $494,750.00 | |
Oct. 16, 2019 | CEO | 33,334 | $17.48 | Sell | $582,678.32 | |
Oct. 15, 2019 | CFO | 25,000 | $15.83 | Sell | $395,750.00 | |
Oct. 14, 2019 | Major Shareholder | 29,127 | $36.72 | Sell | $1,069,543.44 | |
Sept. 30, 2019 | Director | 2,375 | $18.06 | Sell | $42,892.50 | |
Sept. 27, 2019 | Director | 4,000 | $17.99 | Sell | $71,960.00 | |
Sept. 20, 2019 | Director | 2,250 | $20.24 | Sell | $45,540.00 | |
Sept. 16, 2019 | CFO | 25,000 | $20.52 | Sell | $513,000.00 | |
Sept. 5, 2019 | SVP | 15,000 | $17.28 | Buy | $259,200.00 | |
Aug. 16, 2019 | CEO | 12,551 | $18.15 | Sell | $227,800.65 | |
Aug. 16, 2019 | CFO | 5,063 | $18.15 | Sell | $91,893.45 | |
Aug. 16, 2019 | COO | 3,819 | $18.15 | Sell | $69,314.85 |
Insiders are both buying and selling Nektar Therapeutics stock.
The insider traders at Nektar Therapeutics are: Howard W Robin, Gil M. Labrucherie, Jillian B. Thomsen, Robert Chess, Jonathan Zalevsky, John Nicholson, Gil M Labrucherie, Howard W. Robin, Stephen K Doberstein, Jillian B Thomsen, Lutz Lingnau, Mark Andrew Wilson, Ivan P Gergel, Maninder Hora, Jeffrey Robert Ajer, R Scott Greer, Dennis L Winger, Christopher A Kuebler, Myriam Curet, Susan Wang, Christopher A. Kuebler, Roy A Whitfield, Karin Eastham, Curet Myriam, Roy Whitfield, John Northcott, Deep Track Capital, Lp, Stephen K. Doberstein, and Katharina Otto-Bernstein
The most active insider trader at Nektar Therapeutics is Howard W Robin with 49 trades.
Howard W Robin has sold the most Nektar Therapeutics stock with a total value of $84,286,240.28.
Roy A Whitfield has bought the most Nektar Therapeutics stock with a total value of $1,256,500.00.
The most recent insider trade for Nektar Therapeutics was on Nov. 19, 2024.
The single biggest insider buy for Nektar Therapeutics was from Roy A Whitfield with a total value of $628,250.00 on Aug. 10, 2017.
The single biggest insider sell for Nektar Therapeutics was from John Nicholson with a total value of $21,853,694.88 on March 7, 2018.